Eliem Therapeutics Stock Forecast - Daily Balance Of Power
| ELYMDelisted Stock | USD 3.09 0.06 1.90% |
Eliem Stock Forecast is based on your current time horizon.
Eliem |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| 0.3902 | 0.913 |
| Check Eliem Therapeutics Volatility | Backtest Eliem Therapeutics | Trend Details |
Eliem Therapeutics Trading Date Momentum
| On September 16 2024 Eliem Therapeutics was traded for 8.24 at the closing time. The top price for the day was 8.79 and the lowest listed price was 8.03 . The trading volume for the day was 242.7 K. The trading history from September 16, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.60% . The overall trading delta against the current closing price is 5.56% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Eliem Therapeutics to competition
View Eliem Therapeutics Related Equities
| Risk & Return | Correlation |
Eliem Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Eliem Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eliem Therapeutics shares will generate the highest return on investment. By undertsting and applying Eliem Therapeutics stock market strength indicators, traders can identify Eliem Therapeutics entry and exit signals to maximize returns.
Eliem Therapeutics Risk Indicators
The analysis of Eliem Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eliem Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eliem stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.62 | |||
| Standard Deviation | 4.81 | |||
| Variance | 23.13 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Eliem Stock
If you are still planning to invest in Eliem Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eliem Therapeutics' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |